MENA: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in MENA

The MENA's medicaments containing hormones market rose significantly to $X in 2022, picking up by X% against the previous year. Overall, consumption posted strong growth. Over the period under review, the market attained the peak level at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in MENA

In value terms, medicaments containing hormones production rose to $X in 2022 estimated in export price. In general, production enjoyed a prominent increase. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. The level of production peaked at $X in 2020; afterwards, it flattened through to 2022.

Medicaments Containing Hormones Exports

Exports in MENA

In 2022, the amount of medicaments containing hormones but not antibiotics exported in MENA shrank notably to X tons, which is down by X% against 2021 figures. Over the period under review, exports showed a perceptible downturn. The pace of growth appeared the most rapid in 2018 when exports increased by X% against the previous year. The volume of export peaked at X tons in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

In value terms, medicaments containing hormones exports declined to $X in 2022. Overall, exports showed a drastic downturn. The growth pace was the most rapid in 2018 with an increase of X% against the previous year. The level of export peaked at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Kuwait dominates exports structure, resulting at X tons, which was approx. X% of total exports in 2022. Saudi Arabia (X tons) held a minor share of total exports.

Kuwait was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2022. Saudi Arabia (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Kuwait increased by X percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Kuwait ($X) remains the largest medicaments containing hormones supplier in MENA, comprising X% of total exports. The second position in the ranking was taken by Saudi Arabia ($X), with a X% share of total exports.

In Kuwait, medicaments containing hormones exports increased at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

The export price in MENA stood at $X per ton in 2022, surging by X% against the previous year. Over the period under review, the export price, however, continues to indicate a pronounced downturn. The most prominent rate of growth was recorded in 2015 when the export price increased by X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2016 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Saudi Arabia ($X per ton), while Kuwait stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kuwait (X%).

Medicaments Containing Hormones Imports

Imports in MENA

In 2022, after four years of decline, there was significant growth in supplies from abroad of medicaments containing hormones but not antibiotics, when their volume increased by X% to X tons. Overall, imports, however, recorded a perceptible contraction. Over the period under review, imports attained the maximum at X tons in 2015; however, from 2016 to 2022, imports remained at a lower figure.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2022. In general, imports, however, recorded a abrupt shrinkage. The most prominent rate of growth was recorded in 2014 when imports increased by X% against the previous year. Over the period under review, imports reached the maximum at $X in 2015; however, from 2016 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, the United Arab Emirates (X tons) was the key importer of medicaments containing hormones but not antibiotics, constituting X% of total imports. Qatar (X tons) held the second position in the ranking, followed by Saudi Arabia (X tons), Oman (X tons) and Bahrain (X tons). All these countries together held near X% share of total imports. The following importers - Iraq (X tons) and Yemen (X tons) - each accounted for a X% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by the United Arab Emirates (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing hormones importing markets in MENA were the United Arab Emirates ($X), Saudi Arabia ($X) and Qatar ($X), together comprising X% of total imports.

The United Arab Emirates, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in MENA stood at $X per ton in 2022, declining by X% against the previous year. Overall, the import price continues to indicate a abrupt shrinkage. The growth pace was the most rapid in 2014 when the import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2022, the import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Iraq ($X per ton), while Bahrain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Yemen (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform